Beyond Hypersplenism: Splenic Marginal Zone Lymphoma in an Older Adult with Hemoglobin E/Beta-Thalassemia
With improvements in blood safety and availability, along with broad access to safe and effective iron chelation, outcomes for patients with thalassemia have greatly improved over recent decades. Previously a predominantly pediatric condition, thalassemia is now increasingly encountered in an aging population. We describe an adult man with HbE/β-thalassemia whose course was complicated by progressive splenomegaly and cytopenias, initially attributed to his underlying thalassemia. Further evaluation, however, revealed splenic marginal zone lymphoma. After the initiation of anti-B-cell therapy, he experienced rapid clinical improvement and was able to avoid surgical splenectomy. This case highlights how complications ascribed to thalassemia can overlap with other diagnoses that may become more prevalent with age, and demonstrates the importance of maintaining a broad differential when symptoms progress despite appropriate thalassemia-directed management.
Authors
- Elise A. Chong (ORCID: https://orcid.org/0000-0001-8895-1625)
- Aaron N. Cheng (ORCID: https://orcid.org/0000-0001-6984-8884)
- Scott A. Peslak (ORCID: https://orcid.org/0000-0003-1483-1545)
- Farzana Sayani (ORCID: https://orcid.org/0000-0002-8878-9274)
- Rachel K. Lundberg
- Jennifer Cohen
Institutions
- University of Toronto (CA)
- Hospital of the University of Pennsylvania (US)
- Lymphoma Study Association (FR)
- University of Pennsylvania (US)
Publication Details
- Journal
- Hemoglobin
- Published
- 2026-05-12
- DOI
- https://doi.org/10.1080/03630269.2026.2669119
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00